Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance

Urologic Oncology: Seminars and Original Investigations

Volumn 33, Issue 5, 2015, Pages 202.e1-202.e7

  Walton Diaz, Annerleim ^a   Shakir, Nabeel Ahmad ^a   George, Arvin K ^a   Rais Bahrami, Soroush ^a,b,c   Turkbey, Baris ^a   Rothwax, Jason T ^a   Stamatakis, Lambros ^a,d   Hong, Cheng William ^a   Siddiqui, Mohummad Minhaj ^a,e   Okoro, Chinonyerem ^a   Raskolnikov, Dima ^a   Su, Daniel ^a   Shih, Joanna ^a   Han, Hui ^a   Parnes, Howard L ^a   Merino, Maria J ^a   Simon, Richard M ^a   Wood, Bradford J ^a   Choyke, Peter L ^a   Pinto, Peter A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Alabama   (United States)

^c University of Alabama at Birmingham   (United States)

^d WASHINGTON HOSPITAL CENTER   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Diagnosis; Fusion biopsy; Management; Prostate cancer; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER STAGING; CLINICAL TRIAL; DIAGNOSTIC TEST ACCURACY STUDY; FOLLOW UP; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMAGE GUIDED BIOPSY; MAGNETIC RESONANCE IMAGING-ULTRASOUND FUSION-GUIDED PROSTATE BIOPSY DEVICE; MAJOR CLINICAL STUDY; MALE; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATIENT MONITORING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY; DISEASE MANAGEMENT; ECHOGRAPHY; HEALTH SURVEY; INTERVENTIONAL ULTRASONOGRAPHY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; PROSTATIC NEOPLASMS;

ADULT; AGED; DISEASE MANAGEMENT; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; PUBLIC HEALTH SURVEILLANCE; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84929295333     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2015.01.023     Document Type: Article

References (28)

1. Siegel R., Ma J., Zou Z., et al. Cancer statistics, 2014. CA Cancer J Clin 2014, 64:9-29. [PubMed PMID: 24399786].
2. Crawford E.D., Ventii K., Shore N.D. New biomarkers in prostate cancer. Oncology (Williston Park) 2014 Feb, 28:135-142. [PubMed PMID: 24701701].
3. Dall'Era M.A., Albertsen P.C., Bangma C., et al. Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol 2012, 62:976-983. [PubMed PMID: 22698574].
4. Tosoian J.J., JohnBull E., Trock B.J., et al. Pathological outcomes in men with low risk and very low risk prostate cancer: implications on the practice of active surveillance. J Urol 2013, 190:1218-1222. [PubMed PMID: 23643603. Pubmed Central PMCID: 3978170].
5. Klotz L., Zhang L., Lam A., et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010, 28:126-131. [PubMed PMID: 19917860].
6. Stamatakis L., Siddiqui M.M., Nix J.W., et al. Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer 2013, 119:3359-3366. [PubMed PMID: 23821585].
7. Turkbey B., Mani H., Aras O., et al. Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance?. Radiology 2013, 268(1):144-152. [PubMed PMID: 23468576. Pubmed Central PMCID: 3689450].
8. Shakir N.A., George A.K., Siddiqui M.M., et al. Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy. J Urol 2014, 192:1642-1649. [PubMed PMID: 25117476].
9. George A.K., Pinto P.A., Rais-Bahrami S. Multiparametric MRI in the PSA screening era. Biomed Res Int 2014, 2014:465816. http://dx.doi.org/10.1155/2014/465816.
10. Rais-Bahrami S., Siddiqui M.M., Turkbey B., et al. Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol 2013, 190(5):1721-1727. [PubMed PMID: 23727310].
11. Borofsky M.S., Rosenkrantz A.B., Abraham N., et al. Does suspicion of prostate cancer on integrated T2 and diffusion-weighted MRI predict more adverse pathology on radical prostatectomy?. Urology 2013 Jun, 81:1279-1283. [PubMed PMID: 23394882].
12. Rastinehad A.R., Baccala A.A., Chung P.H., et al. D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. J Urol 2011 Mar, 185:815-820. [PubMed PMID: 21239006. Pubmed Central PMCID: 3169005].
13. Sonn G.A., Natarajan S., Margolis D.J., et al. Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. J Urol 2013, 189:86-91. [PubMed PMID: 23158413. Pubmed Central PMCID: 3561472].
14. Vourganti S., Rastinehad A., Yerram N.K., et al. Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol 2012, 188:2152-2157. [PubMed PMID: 23083875. Pubmed Central PMCID: 3895467].
15. Walton Diaz A., Hoang A.N., Turkbey B., et al. Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates?. J Urol 2013 Dec, 190:2020-2025. [PubMed PMID: 23792130].
16. Raskolnikov D., Rais-Bahrami S., George A.K., et al. The role of image guided biopsy targeting in patients with atypical small acinar proliferation. J Urol 2015, 193(2):473-478. http://dx.doi.org/10.1016/j.juro.2014.08.083.
17. Epstein J.I., Walsh P.C., Carmichael M., et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. J Am Med Assoc 1994, 271:368-374. [PubMed PMID: 7506797].
18. Turkbey B., Mani H., Shah V., et al. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol 2011, 186:1818-1824. [PubMed PMID: 21944089].
19. Klotz L. Prostate cancer overdiagnosis and overtreatment. Curr Opin Endocrinol Diabetes Obes 2013, 20:204-209. [PubMed PMID: 23609043].
20. Cooperberg M.R., Carroll P.R., Klotz L. Active surveillance for prostate cancer: progress and promise. J Clin Oncol 2011, 29:3669-3676. [PubMed PMID: 21825257].
21. Moore C.M., Ridout A., Emberton M. The role of MRI in active surveillance of prostate cancer. Curr Opin Urol 2013, 23:261-267. [PubMed PMID: 23478498].
22. Hu J.C., Chang E., Natarajan S., et al. Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply?. J Urol 2014, 192:385-390. [PubMed PMID: 24512956. Pubmed Central PMCID: 4129939].
23. Mullins J.K., Bonekamp D., Landis P., et al. Multiparametric magnetic resonance imaging findings in men with low-risk prostate cancer followed using active surveillance. BJU Int 2013, 111:1037-1045. [PubMed PMID: 23464904. Pubmed Central PMCID: 3978179].
24. Bjurlin M.A., Wysock J.S., Taneja S.S. Optimization of prostate biopsy: review of technique and complications. Urol Clin North Am 2014 May, 41:299-313. [PubMed PMID: 24725491. Pubmed Central PMCID: 4151475].
25. Siddiqui M.M., Rais-Bahrami S., Truong H., et al. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol 2013, 64:713-719. [PubMed PMID: 23787357].
26. Pinto P.A., Chung P.H., Rastinehad A.R., et al. Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol 2011, 186:1281-1285. [PubMed PMID: 21849184. Pubmed Central PMCID: 3193933].
27. Rastinehad A.R., Turkbey B., Rastinehad A.R., Salami S.S., et al. Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy. J Urol 2014, 191:1749-1754. [PubMed PMID: 24333515].
28. Rais-Bahrami S., Turkbey B., Rastinehad A.R., et al. Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up. Diagn Interv Radiol 2014, 20:293-298. [PubMed PMID: 24808435].